Strides Pharma Science's Stock Hits All-Time High, Outperforms Sector by 2.06%

Strides Pharma Science, a midcap pharmaceutical company, has seen a surge in its stock price, reaching an all-time high on October 13, 2024. The stock has been performing well in the market, with MarketsMOJO giving it a 'Hold' rating. It has also been listed as part of the Momentumnow Stocks on MarketsMOJO since April 3, 2024. On October 13, the stock hit a new 52-week and all-time high of Rs.1586.1, outperforming the sector by 2.06%. This marks the fourth consecutive day of gains for the stock, with a 10.6% increase in returns during this period. The stock also touched an intraday high of Rs.1586.1, a 4.83% increase. Strides Pharma is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market. In the past year, the company's stock has shown a remarkable performance of 209.11%, while the Sensex has only seen a 22.43% increase. As a midcap pharmaceutical company, Strides Pharma Science has shown strong growth and potential in the market. With its current performance and positive outlook, it is definitely a stock to keep an eye on.